肝硬化患者医院获得性与社区获得性急性肾损伤的前瞻性研究
该前瞻性研究纳入519例住院肝硬化患者,比较医院获得性急性肾损伤(H-AKI)与社区获得性急性肾损伤(C-AKI)的差异。结果显示H-AKI发生率为10%,C-AKI为25%;仅C-AKI与90天死亡率升高独立相关,且C-AKI分期3与出院后新发慢性肾病(CKD)/CKD进展独立相关。
要点
- 肝硬化住院患者中C-AKI发生率为25%,H-AKI为10%。
- 仅C-AKI与90天死亡率升高独立相关,H-AKI无此关联。
- C-AKI分期3与新发CKD/CKD进展独立相关,建议出院后密切监测。
核心结论
- 与H-AKI相比,C-AKI与肝硬化患者死亡率增加及新发CKD/CKD进展相关。
- C-AKI患者可能从出院后频繁监测中获益以改善结局。
研究设计与样本
- 前瞻性研究,纳入519例住院肝硬化患者,随访至出院后90天以评估死亡率。
- 主要结局为90天内死亡率;次要结局为90天后新发CKD/CKD进展。
- 采用Cox比例风险模型和 logistic 回归分析AKI与结局的独立关联。
主要发现
- H-AKI发生率为10%,C-AKI发生率为25%。
- 校正MELD-Na后,仅C-AKI与死亡率升高独立相关(HR 1.64,95%CI 1.04-2.57,P=0.033)。
- 校正ACLF后,仅C-AKI与死亡率升高独立相关(HR 2.44,95%CI 1.63-3.65,P<0.001)。
- 单变量分析中C-AKI与新发CKD/CKD进展相关(OR 2.13,95%CI 1.09-4.14,P=0.027),但多变量分析中无独立关联。
- 按AKI分期二分时,C-AKI分期3与新发CKD/CKD进展独立相关(OR 4.79,95%CI 1.11-20.57,P=0.035)。
临床怎么用
- 对肝硬化合并C-AKI患者,出院后应加强肾功能监测以改善结局。
- C-AKI分期3患者需重点关注新发CKD或CKD进展风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In patients with cirrhosis, differences between acute kidney injury (AKI) at the time of hospital admission (community-acquired) and AKI occurring during hospitalization (hospital-acquired) have not been explored. We aimed to compare patients with hospital-acquired AKI (H-AKI) and community-acquired AKI (C-AKI) in a large, prospective study. METHODS: Hospitalized patients with cirrhosis were enrolled (N = 519) and were followed for 90 days after discharge for mortality. The primary outcome was mortality within 90 days; secondary outcomes were the development of de novo chronic kidney disease (CKD)/progression of CKD after 90 days. Cox proportional hazards and logistic regressions were used to determine the independent association of either AKI for primary and secondary outcomes, respectively. RESULTS: H-AKI occurred in 10%, and C-AKI occurred in 25%. In multivariable Cox models adjusting for significant confounders, only patients with C-AKI had a higher risk for mortality adjusting for model for end-stage liver disease-Na: (hazard ratio 1.64, 95% confidence interval [CI] 1.04-2.57, P = 0.033) and adjusting for acute on chronic liver failure: (hazard ratio 2.44, 95% CI 1.63-3.65, P < 0.001). In univariable analysis, community-acquired-AKI, but not hospital-acquired-AKI, was associated with de novo CKD/progression of CKD (odds ratio 2.13, 95% CI 1.09-4.14, P = 0.027), but in multivariable analysis, C-AKI was not independently associated with de novo CKD/progression of CKD. However, when AKI was dichotomized by stage, C-AKI stage 3 was independently associated with de novo CKD/progression of CKD (odds ratio 4.79, 95% CI 1.11-20.57, P = 0.035). DISCUSSION: Compared with H-AKI, C-AKI is associated with increased mortality and de novo CKD/progression of CKD in patients with cirrhosis. Patients with C-AKI may benefit from frequent monitoring after discharge to improve outcomes.
引用
- Patidar KR, Shamseddeen H, Xu C, et al. Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study. Am J Gastroenterol. 2020. PMID: 32371628. doi:10.14309/ajg.0000000000000670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。